Adenosinergic psychopharmaceuticals: just an extra cup of coffee?

The L-type calcium channel blocker nimodipine mitigates "learned helplessness" in rats

We assessed the effect of nimodipine, an L-type calcium channel blocker, on the escape deficit induced by prior exposure to inescapable shock in rats in four experiments. In Experiment 1, we injected rats at each of three time points (i.e., before shock exposure, after shock exposure, and before shuttle escape testing) with one of four doses of nimodipine (0, 0.5, 2.5, 5.0 mg/kg). The 5.0-mg/kg dose was most effective, acting to reduce shuttle escape latencies of inescapably shocked rats to a level comparable with nonshocked controls. No benefit occurred in Experiment 2, however, when nimodipine was administered at only one of the three time points used in the first experiment. Moreover, escape performance did not improve when rats received injections of nimodipine on the 2 days prior the experiment, and then one additional injection at one of the three time points identified above in Experiment 3. Finally, administration of nimodipine at two of the three time points did improve escape responding, but only when injected immediately prior both to shock exposure and the shuttle escape test.

Caffeine and selective visual processing

This work addressed five issues: a) Does caffeine modulate electroencephalogram (EEG) background activity in a manner consistent with the idea of cortical "arousal"? b) Is performance in a simple speeded task improved under caffeine? c) Is visual processing more selective under caffeine? d) Does caffeine affect sensory discrimination? and e) Does it affect motor processes? We presented 16 subjects with a visual selection task under conditions of either caffeine or placebo. Background EEG data, gathered before administration of the task, revealed that caffeine resulted in lower slow-alpha power, relative to placebo, which is consistent with the idea of increased cortical "arousal." During the selection task, subjects had to respond manually to a given target conjunction of spatial frequency and orientation. Other conjunctions shared spatial frequency, orientation, or neither with the target. The four conjunctions were presented in a random sequence, with SOAs ranging between 750 and 950 ms. Event-related potentials (ERPs) to the conjunctions were recorded at standard scalp locations Fz, Cz, Pz, and Oz. Under caffeine, subjects made faster responses to target conjunctions (382.9 vs. 404.5 ms) and more hits, whereas the false-alarm rate was equal across conditions. Caffeine did not affect the selection potentials normally obtained in this task by subtracting, from ERPs to nontargets with the target spatial frequency, those to nontargets with the other frequency. However, an early differential positivity (50-160 ms) was found specifically under caffeine, indicative of increased selectivity. Difference ERPs as a function of physical parameters were not affected by caffeine, indicating no effect on sensory discrimination. Onsets of response-related lateralizations above the motor cortex were not affected by caffeine, suggesting that the shorter reaction times under caffeine were due to faster central or peripheral motor processes.

(3H)dipyridamole and (3H)nitrobenzylthioinosine binding sites at the human parietal cortex and erythrocyte adenosine transporter: a comparison

We compared the binding sites of the adenosine transport inhibitors (3H)dipyridamole (DPR) and (3H)nitrobenzylthioinosine (NBI) in human parietal cortex and erythrocytes. In comparison with guinea pig (3H)DPR marked only slightly more binding sites than (3H)NBI with a Bmax of 1080 +/- 29 and 780 +/- 7 fmol/mg protein respectively in parietal cortex and 24288 +/- 2725 and 20875 +/- 1905 fmol/mg protein respectively in erythrocytes. NBI displaced (3H)DPR binding completely from its binding sites at about KD/2 concentrations in parietal cortex as well as erythrocytes with inhibition constants comparable to its dissociation constants. Lineweaver-Burke analysis in erythrocytes indicated a competitive inhibition of (3H)DPR binding by NBI. Pharmacological characterization of (3H)DPR binding sites in human erythrocytes is consistent with their localization on adenosine transporters. These findings provide evidence that as opposed to guinea pig (3H)DPR and (3H)NBI largely label binding sites to the same adenosine transporter in human erythrocytes and parietal cortex.